You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 74.8 KDa. Observed: 80-120 KDa, reducing conditions
Human
Gly24-Glu443
C-Fc-Avi
20 μg, 100 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 91.6 KDa. Observed: 105-150 KDa, reducing conditions
Human
Leu20-Pro603
C-Fc
50 μg, 500 μg, 1 mg, 10 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 53.5 KDa. Observed: 70-135 KDa, reducing conditions
Human
Ala21-Ile505
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 74 KDa. Observed: 70-145 KDa, reducing conditions
Mouse
Val20-Met433
C-Fc
10 μg, 50 μg, 500 μg, 1 mgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 62.8 KDa. Observed: 63-88 KDa, reducing conditions
Human
Thr155His454
C-Fc-Avi
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 21.5 KDa. Observed: 24-36 KDa, reducing conditions
Human
Gln45Pro193
N-6His-Flag
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 71.9 KDa. Observed: (15-19)&(60-80) KDa, reducing conditions
Human
Gln31-Gln692
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.6 Kda. Observed: 26-40 KDa, reducing conditions
Mouse
Tyr65-Arg267
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 95.9 Kda. Observed: 100-155 KDa, reducing conditions
Human
Leu48-Ile875
N-6His
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 29.6 Kda. Observed: 26-34 KDa, reducing conditions
Human
Ala2-Lys254
N-6His
10 μg, 50 μg, 500 μg, 1 mg